0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global TACE Embolic Microspheres Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-25F17824
Home | Market Reports | Health| Health Conditions| Cancer
Global TACE Embolic Microspheres Market Research Report 2024
BUY CHAPTERS

Global TACE Embolic Microspheres Market Research Report 2026

Code: QYRE-Auto-25F17824
Report
2026-02-11
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

TACE Embolic Microspheres Market Size

The global TACE Embolic Microspheres market was valued at US$ 1577 million in 2025 and is anticipated to reach US$ 2770 million by 2032, at a CAGR of 8.5% from 2026 to 2032.

TACE Embolic Microspheres Market

TACE Embolic Microspheres Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on TACE Embolic Microspheres competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
TACE embolic microspheres are a type of microsphere embolic agent used in transcatheter arterial chemoembolization (TACE) therapy. TACE stands for Transarterial Chemoembolization, which is a medical procedure used primarily in the treatment of liver cancer. It involves delivering chemotherapy drugs directly to a tumor in the liver while also blocking the blood supply to the tumor. This dual action helps to both directly attack the cancer cells and cut off their blood supply, thereby shrinking or slowing the tumor's growth. TACE embolic microspheres can be loaded with chemotherapy drugs (such as doxorubicin) or used alone to embolize (block) the blood vessels. By blocking these vessels, the microspheres prevent the tumor from receiving oxygen and nutrients, thereby reducing its ability to grow and survive.
In 2024, global TACE embolic microspheres production reached approximately 1186 L, with an average global market price of around US$1250 per ml. TACE embolic microspheres typically have a single-line production capacity of approximately 20-100 liters/year. The industry typically enjoys high gross profit margins of approximately 60% to 80%, primarily due to their high added value and technological barriers. Raw materials (polymers and drugs) account for the largest portion of the cost structure, approximately 30% to 40%, with the remainder comprising production consumables and packaging materials, labor costs, and manufacturing expenses. Upstream raw material suppliers provide key raw materials such as biodegradable polymers and drug-loaded materials. Downstream suppliers primarily include hospitals and medical institutions (as end users, performing TACE treatments) and dealers and distributors (responsible for regional product sales and promotion).
TACE embolic microsphere sector is transitioning from simple occlusion materials toward sophisticated drug-eluting and targeted-release platforms. Material innovation and drug-delivery design are enabling more predictable intratumoral exposure and procedure standardization, which aligns with clinicians’ demand for improved efficacy and safety. Regulatory acceptance and robust clinical evidence are the primary gates to wide hospital adoption; manufacturers that pair reproducible manufacturing with compelling clinical data will gain preferential uptake. Cost and supply considerations mean basic embolics will remain relevant in lower-resource settings, while high-value DEMs will dominate centers focused on outcome optimization. Overall, the market favors companies that integrate controlled-release technology, scalable production, and clinical partnerships.
This report delivers a comprehensive overview of the global TACE Embolic Microspheres market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding TACE Embolic Microspheres. The TACE Embolic Microspheres market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global TACE Embolic Microspheres market comprehensively. Regional market sizes by Type, by Application, by Size, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist TACE Embolic Microspheres manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of TACE Embolic Microspheres Market Report

Report Metric Details
Report Name TACE Embolic Microspheres Market
Accounted market size in 2025 US$ 1577 million
Forecasted market size in 2032 US$ 2770 million
CAGR 8.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Common Embolic Microspheres
  • Drug-Loadable Embolic Microspheres
Segment by Size
  • 1G (<100μm)
  • 2 G (≥100μm)
by Application
  • Primary Liver Cancer
  • Colorectal Cancer Liver Metastasis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Mermaid Medical, Cardiolink Science, Suzhou Haowei Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Size, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for TACE Embolic Microspheres manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines TACE Embolic Microspheres sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is TACE Embolic Microspheres Market growing?

Ans: The TACE Embolic Microspheres Market witnessing a CAGR of 8.5% during the forecast period 2026-2032.

What is the TACE Embolic Microspheres Market size in 2032?

Ans: The TACE Embolic Microspheres Market size in 2032 will be US$ 2770 million.

Who are the main players in the TACE Embolic Microspheres Market report?

Ans: The main players in the TACE Embolic Microspheres Market are Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Mermaid Medical, Cardiolink Science, Suzhou Haowei Medical Technology

What are the Application segmentation covered in the TACE Embolic Microspheres Market report?

Ans: The Applications covered in the TACE Embolic Microspheres Market report are Primary Liver Cancer, Colorectal Cancer Liver Metastasis, Others

What are the Type segmentation covered in the TACE Embolic Microspheres Market report?

Ans: The Types covered in the TACE Embolic Microspheres Market report are Common Embolic Microspheres, Drug-Loadable Embolic Microspheres

1 TACE Embolic Microspheres Market Overview
1.1 Product Definition
1.2 TACE Embolic Microspheres by Type
1.2.1 Global TACE Embolic Microspheres Market Value by Type: 2025 vs 2032
1.2.2 Common Embolic Microspheres
1.2.3 Drug-Loadable Embolic Microspheres
1.3 TACE Embolic Microspheres by Size
1.3.1 Global TACE Embolic Microspheres Market Value by Size: 2025 vs 2032
1.3.2 1G (<100μm)
1.3.3 2 G (≥100μm)
1.4 TACE Embolic Microspheres by Application
1.4.1 Global TACE Embolic Microspheres Market Value by Application: 2025 vs 2032
1.4.2 Primary Liver Cancer
1.4.3 Colorectal Cancer Liver Metastasis
1.4.4 Others
1.5 Global TACE Embolic Microspheres Market Size Estimates and Forecasts
1.5.1 Global TACE Embolic Microspheres Revenue 2021–2032
1.5.2 Global TACE Embolic Microspheres Sales 2021–2032
1.5.3 Global TACE Embolic Microspheres Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 TACE Embolic Microspheres Market Competition by Manufacturers
2.1 Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
2.2 Global TACE Embolic Microspheres Revenue Market Share by Manufacturers (2021–2026)
2.3 Global TACE Embolic Microspheres Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of TACE Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of TACE Embolic Microspheres, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of TACE Embolic Microspheres, Product Types and Applications
2.7 Global Key Manufacturers of TACE Embolic Microspheres, Date of Entry into the Industry
2.8 Global TACE Embolic Microspheres Market Competitive Situation and Trends
2.8.1 Global TACE Embolic Microspheres Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global TACE Embolic Microspheres Players Market Share by Revenue
2.8.3 Global TACE Embolic Microspheres Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global TACE Embolic Microspheres Market Scenario by Region
3.1 Global TACE Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global TACE Embolic Microspheres Sales by Region: 2021–2032
3.2.1 Global TACE Embolic Microspheres Sales by Region: 2021–2026
3.2.2 Global TACE Embolic Microspheres Sales by Region: 2027–2032
3.3 Global TACE Embolic Microspheres Revenue by Region: 2021–2032
3.3.1 Global TACE Embolic Microspheres Revenue by Region: 2021–2026
3.3.2 Global TACE Embolic Microspheres Revenue by Region: 2027–2032
3.4 North America TACE Embolic Microspheres Market Facts & Figures by Country
3.4.1 North America TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America TACE Embolic Microspheres Sales by Country (2021–2032)
3.4.3 North America TACE Embolic Microspheres Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe TACE Embolic Microspheres Market Facts & Figures by Country
3.5.1 Europe TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe TACE Embolic Microspheres Sales by Country (2021–2032)
3.5.3 Europe TACE Embolic Microspheres Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TACE Embolic Microspheres Market Facts & Figures by Region
3.6.1 Asia Pacific TACE Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific TACE Embolic Microspheres Sales by Region (2021–2032)
3.6.3 Asia Pacific TACE Embolic Microspheres Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America TACE Embolic Microspheres Market Facts & Figures by Country
3.7.1 Latin America TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America TACE Embolic Microspheres Sales by Country (2021–2032)
3.7.3 Latin America TACE Embolic Microspheres Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa TACE Embolic Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa TACE Embolic Microspheres Sales by Country (2021–2032)
3.8.3 Middle East and Africa TACE Embolic Microspheres Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global TACE Embolic Microspheres Sales by Type (2021–2032)
4.1.1 Global TACE Embolic Microspheres Sales by Type (2021–2026)
4.1.2 Global TACE Embolic Microspheres Sales by Type (2027–2032)
4.1.3 Global TACE Embolic Microspheres Sales Market Share by Type (2021–2032)
4.2 Global TACE Embolic Microspheres Revenue by Type (2021–2032)
4.2.1 Global TACE Embolic Microspheres Revenue by Type (2021–2026)
4.2.2 Global TACE Embolic Microspheres Revenue by Type (2027–2032)
4.2.3 Global TACE Embolic Microspheres Revenue Market Share by Type (2021–2032)
4.3 Global TACE Embolic Microspheres Price by Type (2021–2032)
5 Segment by Application
5.1 Global TACE Embolic Microspheres Sales by Application (2021–2032)
5.1.1 Global TACE Embolic Microspheres Sales by Application (2021–2026)
5.1.2 Global TACE Embolic Microspheres Sales by Application (2027–2032)
5.1.3 Global TACE Embolic Microspheres Sales Market Share by Application (2021–2032)
5.2 Global TACE Embolic Microspheres Revenue by Application (2021–2032)
5.2.1 Global TACE Embolic Microspheres Revenue by Application (2021–2026)
5.2.2 Global TACE Embolic Microspheres Revenue by Application (2027–2032)
5.2.3 Global TACE Embolic Microspheres Revenue Market Share by Application (2021–2032)
5.3 Global TACE Embolic Microspheres Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo TACE Embolic Microspheres Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Merit Medical
6.3.1 Merit Medical Company Information
6.3.2 Merit Medical Description and Business Overview
6.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
6.3.5 Merit Medical Recent Developments/Updates
6.4 Varian
6.4.1 Varian Company Information
6.4.2 Varian Description and Business Overview
6.4.3 Varian TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Varian TACE Embolic Microspheres Product Portfolio
6.4.5 Varian Recent Developments/Updates
6.5 Sirtex Medical
6.5.1 Sirtex Medical Company Information
6.5.2 Sirtex Medical Description and Business Overview
6.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
6.5.5 Sirtex Medical Recent Developments/Updates
6.6 Suzhou Hengrui Medical Equipment
6.6.1 Suzhou Hengrui Medical Equipment Company Information
6.6.2 Suzhou Hengrui Medical Equipment Description and Business Overview
6.6.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
6.6.5 Suzhou Hengrui Medical Equipment Recent Developments/Updates
6.7 ABK Biomedical
6.7.1 ABK Biomedical Company Information
6.7.2 ABK Biomedical Description and Business Overview
6.7.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
6.7.5 ABK Biomedical Recent Developments/Updates
6.8 Mermaid Medical
6.8.1 Mermaid Medical Company Information
6.8.2 Mermaid Medical Description and Business Overview
6.8.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
6.8.5 Mermaid Medical Recent Developments/Updates
6.9 Cardiolink Science
6.9.1 Cardiolink Science Company Information
6.9.2 Cardiolink Science Description and Business Overview
6.9.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
6.9.5 Cardiolink Science Recent Developments/Updates
6.10 Suzhou Haowei Medical Technology
6.10.1 Suzhou Haowei Medical Technology Company Information
6.10.2 Suzhou Haowei Medical Technology Description and Business Overview
6.10.3 Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Suzhou Haowei Medical Technology TACE Embolic Microspheres Product Portfolio
6.10.5 Suzhou Haowei Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TACE Embolic Microspheres Industry Chain Analysis
7.2 TACE Embolic Microspheres Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TACE Embolic Microspheres Production Mode & Process Analysis
7.4 TACE Embolic Microspheres Sales and Marketing
7.4.1 TACE Embolic Microspheres Sales Channels
7.4.2 TACE Embolic Microspheres Distributors
7.5 TACE Embolic Microspheres Customer Analysis
8 TACE Embolic Microspheres Market Dynamics
8.1 TACE Embolic Microspheres Industry Trends
8.2 TACE Embolic Microspheres Market Drivers
8.3 TACE Embolic Microspheres Market Challenges
8.4 TACE Embolic Microspheres Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global TACE Embolic Microspheres Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global TACE Embolic Microspheres Market Value by Size (US$ Million), 2025 vs 2032
 Table 3. Global TACE Embolic Microspheres Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global TACE Embolic Microspheres Market Competitive Situation by Manufacturers in 2025
 Table 5. Global TACE Embolic Microspheres Sales (L) of Key Manufacturers (2021–2026)
 Table 6. Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global TACE Embolic Microspheres Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global TACE Embolic Microspheres Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market TACE Embolic Microspheres Average Price (US$/mL) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of TACE Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of TACE Embolic Microspheres, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of TACE Embolic Microspheres, Product Types and Applications
 Table 13. Global Key Manufacturers of TACE Embolic Microspheres, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global TACE Embolic Microspheres Companies by Tier (Tier 1, Tier 2, Tier 3), based on TACE Embolic Microspheres Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global TACE Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global TACE Embolic Microspheres Sales by Region (L), 2021–2026
 Table 19. Global TACE Embolic Microspheres Sales Market Share by Region (2021–2026)
 Table 20. Global TACE Embolic Microspheres Sales by Region (L), 2027–2032
 Table 21. Global TACE Embolic Microspheres Sales Market Share by Region (2027–2032)
 Table 22. Global TACE Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
 Table 23. Global TACE Embolic Microspheres Revenue Market Share by Region (2021–2026)
 Table 24. Global TACE Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
 Table 25. Global TACE Embolic Microspheres Revenue Market Share by Region (2027–2032)
 Table 26. North America TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America TACE Embolic Microspheres Sales by Country (L), 2021–2026
 Table 28. North America TACE Embolic Microspheres Sales by Country (L), 2027–2032
 Table 29. North America TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 30. North America TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe TACE Embolic Microspheres Sales by Country (L), 2021–2026
 Table 33. Europe TACE Embolic Microspheres Sales by Country (L), 2027–2032
 Table 34. Europe TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific TACE Embolic Microspheres Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific TACE Embolic Microspheres Sales by Region (L), 2021–2026
 Table 38. Asia Pacific TACE Embolic Microspheres Sales by Region (L), 2027–2032
 Table 39. Asia Pacific TACE Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific TACE Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America TACE Embolic Microspheres Sales by Country (L), 2021–2026
 Table 43. Latin America TACE Embolic Microspheres Sales by Country (L), 2027–2032
 Table 44. Latin America TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa TACE Embolic Microspheres Sales by Country (L), 2021–2026
 Table 48. Middle East and Africa TACE Embolic Microspheres Sales by Country (L), 2027–2032
 Table 49. Middle East and Africa TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 51. Global TACE Embolic Microspheres Sales (L) by Type (2021–2026)
 Table 52. Global TACE Embolic Microspheres Sales (L) by Type (2027–2032)
 Table 53. Global TACE Embolic Microspheres Sales Market Share by Type (2021–2026)
 Table 54. Global TACE Embolic Microspheres Sales Market Share by Type (2027–2032)
 Table 55. Global TACE Embolic Microspheres Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global TACE Embolic Microspheres Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global TACE Embolic Microspheres Revenue Market Share by Type (2021–2026)
 Table 58. Global TACE Embolic Microspheres Revenue Market Share by Type (2027–2032)
 Table 59. Global TACE Embolic Microspheres Price (US$/mL) by Type (2021–2026)
 Table 60. Global TACE Embolic Microspheres Price (US$/mL) by Type (2027–2032)
 Table 61. Global TACE Embolic Microspheres Sales (L) by Application (2021–2026)
 Table 62. Global TACE Embolic Microspheres Sales (L) by Application (2027–2032)
 Table 63. Global TACE Embolic Microspheres Sales Market Share by Application (2021–2026)
 Table 64. Global TACE Embolic Microspheres Sales Market Share by Application (2027–2032)
 Table 65. Global TACE Embolic Microspheres Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global TACE Embolic Microspheres Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global TACE Embolic Microspheres Revenue Market Share by Application (2021–2026)
 Table 68. Global TACE Embolic Microspheres Revenue Market Share by Application (2027–2032)
 Table 69. Global TACE Embolic Microspheres Price (US$/mL) by Application (2021–2026)
 Table 70. Global TACE Embolic Microspheres Price (US$/mL) by Application (2027–2032)
 Table 71. Boston Scientific Company Information
 Table 72. Boston Scientific Description and Business Overview
 Table 73. Boston Scientific TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 74. Boston Scientific TACE Embolic Microspheres Product
 Table 75. Boston Scientific Recent Developments/Updates
 Table 76. Terumo Company Information
 Table 77. Terumo Description and Business Overview
 Table 78. Terumo TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 79. Terumo TACE Embolic Microspheres Product
 Table 80. Terumo Recent Developments/Updates
 Table 81. Merit Medical Company Information
 Table 82. Merit Medical Description and Business Overview
 Table 83. Merit Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 84. Merit Medical TACE Embolic Microspheres Product
 Table 85. Merit Medical Recent Developments/Updates
 Table 86. Varian Company Information
 Table 87. Varian Description and Business Overview
 Table 88. Varian TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 89. Varian TACE Embolic Microspheres Product
 Table 90. Varian Recent Developments/Updates
 Table 91. Sirtex Medical Company Information
 Table 92. Sirtex Medical Description and Business Overview
 Table 93. Sirtex Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 94. Sirtex Medical TACE Embolic Microspheres Product
 Table 95. Sirtex Medical Recent Developments/Updates
 Table 96. Suzhou Hengrui Medical Equipment Company Information
 Table 97. Suzhou Hengrui Medical Equipment Description and Business Overview
 Table 98. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 99. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product
 Table 100. Suzhou Hengrui Medical Equipment Recent Developments/Updates
 Table 101. ABK Biomedical Company Information
 Table 102. ABK Biomedical Description and Business Overview
 Table 103. ABK Biomedical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 104. ABK Biomedical TACE Embolic Microspheres Product
 Table 105. ABK Biomedical Recent Developments/Updates
 Table 106. Mermaid Medical Company Information
 Table 107. Mermaid Medical Description and Business Overview
 Table 108. Mermaid Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 109. Mermaid Medical TACE Embolic Microspheres Product
 Table 110. Mermaid Medical Recent Developments/Updates
 Table 111. Cardiolink Science Company Information
 Table 112. Cardiolink Science Description and Business Overview
 Table 113. Cardiolink Science TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 114. Cardiolink Science TACE Embolic Microspheres Product
 Table 115. Cardiolink Science Recent Developments/Updates
 Table 116. Suzhou Haowei Medical Technology Company Information
 Table 117. Suzhou Haowei Medical Technology Description and Business Overview
 Table 118. Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 119. Suzhou Haowei Medical Technology TACE Embolic Microspheres Product
 Table 120. Suzhou Haowei Medical Technology Recent Developments/Updates
 Table 121. Key Raw Materials Lists
 Table 122. Raw Materials Key Suppliers Lists
 Table 123. TACE Embolic Microspheres Distributors List
 Table 124. TACE Embolic Microspheres Customers List
 Table 125. TACE Embolic Microspheres Market Trends
 Table 126. TACE Embolic Microspheres Market Drivers
 Table 127. TACE Embolic Microspheres Market Challenges
 Table 128. TACE Embolic Microspheres Market Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources
 Table 132. Authors List of This Report


List of Figures
 Figure 1. Product Picture of TACE Embolic Microspheres
 Figure 2. Global TACE Embolic Microspheres Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global TACE Embolic Microspheres Market Share by Type: 2025 & 2032
 Figure 4. Common Embolic Microspheres Product Picture
 Figure 5. Drug-Loadable Embolic Microspheres Product Picture
 Figure 6. Global TACE Embolic Microspheres Market Value by Size (US$ Million), 2021–2032
 Figure 7. Global TACE Embolic Microspheres Market Share by Size: 2025 vs 2032
 Figure 8. 1G (<100μm) Product Picture
 Figure 9. 2 G (≥100μm) Product Picture
 Figure 10. Global TACE Embolic Microspheres Market Value by Application (US$ Million), 2021–2032
 Figure 11. Global TACE Embolic Microspheres Market Share by Application: 2025 & 2032
 Figure 12. Primary Liver Cancer
 Figure 13. Colorectal Cancer Liver Metastasis
 Figure 14. Others
 Figure 15. Global TACE Embolic Microspheres Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global TACE Embolic Microspheres Market Size (US$ Million), 2021–2032
 Figure 17. Global TACE Embolic Microspheres Sales (L), 2021–2032
 Figure 18. Global TACE Embolic Microspheres Average Price (US$/mL), 2021–2032
 Figure 19. TACE Embolic Microspheres Report Years Considered
 Figure 20. TACE Embolic Microspheres Sales Share by Manufacturers in 2025
 Figure 21. Global TACE Embolic Microspheres Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global TACE Embolic Microspheres Players: Market Share by Revenue in TACE Embolic Microspheres in 2025
 Figure 23. TACE Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global TACE Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 26. North America TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 27. United States TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 30. Europe TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 31. Germany TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific TACE Embolic Microspheres Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific TACE Embolic Microspheres Revenue Market Share by Region (2021–2032)
 Figure 38. China TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. China Taiwan TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Southeast Asia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 46. Latin America TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Colombia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of TACE Embolic Microspheres by Type (2021–2032)
 Figure 57. Global Revenue Market Share of TACE Embolic Microspheres by Type (2021–2032)
 Figure 58. Global TACE Embolic Microspheres Price (US$/mL) by Type (2021–2032)
 Figure 59. Global Sales Market Share of TACE Embolic Microspheres by Application (2021–2032)
 Figure 60. Global Revenue Market Share of TACE Embolic Microspheres by Application (2021–2032)
 Figure 61. Global TACE Embolic Microspheres Price (US$/mL) by Application (2021–2032)
 Figure 62. TACE Embolic Microspheres Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture